HKU Researchers Shed Light on Overcoming Cancer Drug Resistance Unlocking Potential to Expand Use of PARP Inhibitors Across Cancer Types
August 01, 2024
August 01, 2024
HONG KONG, Aug. 1 (TNSres) -- The University of Hong Kong issued the following news release:
A research team led by Professor Ying Wai CHAN from the School of Biological Sciences at The University of Hong Kong (HKU) has made a significant breakthrough in understanding how cancer cells develop resistance to a class of cancer drugs known as PARP inhibitors. Their latest findings, published in Cell Reports, reveal the crucial role of a protein named FANCM in promoting resistance to the . . .
A research team led by Professor Ying Wai CHAN from the School of Biological Sciences at The University of Hong Kong (HKU) has made a significant breakthrough in understanding how cancer cells develop resistance to a class of cancer drugs known as PARP inhibitors. Their latest findings, published in Cell Reports, reveal the crucial role of a protein named FANCM in promoting resistance to the . . .